Neuroimmune Signaling in Drug Actions and Addictions

Brings together cutting-edge research on neuroimmune signaling in drug actions and addictions

Changhai Cui (Volume editor), David Shurtleff (Volume editor), R. Adron Harris (Volume editor)

9780128012840, Elsevier Science

Hardback, published 29 August 2014

512 pages
22.9 x 15.1 x 3 cm, 1.07 kg

This well-established international series examines major areas of basic and clinical research within neuroscience, as well as emerging and promising subfields. This volume concentrates on Neuroimmune Signaling in Drug Actions and Addictions.

1. Neuroimmune Mechanisms of Alcohol and Drug Addiction
2. Neuroimmune Pathways in Alcohol Consumption: Evidence from Behavioral and

Genetic Studies in Rodents and Humans

3. Fetal Alcohol Spectrum Disorders and Neuroimmune Changes
4. Role of Microglia in Regulation of Ethanol Neurotoxic Action
5. Functions of the Chemokine Receptor CXCR4 in the Central Nervous System and its Regulation by µ-opioid Receptors
6. Discovery of a Novel Site of Opioid Action at the Innate Immune Pattern Recognition Receptor TLR4 has Profound Implications for Addiction Research
7. Neuroimmune Basis of Methamphetamine Toxicity
8. Marijuana Use and Brain Immune Mechanisms
9. Interactions of HIV and Drugs of Abuse: The Importance of Glia, Neural Progenitors, and Host Genetic Factors
10. Neuroimmune Basis of Alcoholic Brain Damage
11. Converging Actions of Alcohol on Liver and Brain Immune Signaling
12. Opportunities for the Development of Neuroimmune Therapies in Addiction
13. NeuroHIV and Use of Addictive Substances

Subject Areas: Developmental biology [PSC], Neurosciences [PSAN], Addiction & therapy [MMZR]